Condition
Antipsychotics and Neuroleptics Toxicity
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05033119Completed
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
NCT06357195Active Not Recruiting
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
NCT06200584Not ApplicableCompletedPrimary
Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics
NCT04668248Not ApplicableCompleted
Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing
NCT04575103Not ApplicableUnknown
Monitoring of Arrhythmias in Patients Treated With Antipsychotics
Showing all 5 trials